White Papers
Pharmaceutical companies that are seeking ways to engage and partner with integrated delivery networks must understand this: IDNs are evolving in ways that have a profound effect on how healthcare is managed, what care paths are followed and which populations are carved out for special attention.
TGaS Advisors, a division of Trinity Life Sciences, conducted 15 in-depth interviews with key decision-makers from advanced healthcare systems in the U.S. to understand their perspectives on what is driving IDNs and what they…
Read Now
Webinars
Available On Demand
Unlock forecasting value with revolutionary technology
Collaborate on and update models in the cloud
Incorporate stakeholder feedback into forecasts on the fly
Manage effective and efficient stakeholder communication
Trinity CloudCast is an online solution, delivered with Trinity’s best-in-class forecasting services, that streamlines forecasting activities to drive effective and efficient business decisions across life sciences organizations.
Come join us for a virtual discussion, where Susheel Sukhtankar, Partner & Head of Commercial Analytics, Adrian Watson, Director of Forecasting and Akash Kundu, Associate…
Watch Now
Webinars
Available On Demand
The pharmaceutical market in China has experienced tremendous growth over the past several decades and is becoming increasingly important. While many life sciences organizations consider China to be a ‘must win’ market, commercial success can be elusive. Despite the large patient base and recent economic and political tailwinds driving the advancement of the healthcare industry, sales for innovative drugs in China are often only a fraction of those in the U.S. The complex and rapidly evolving market dynamics require companies…
Watch Now
Webinars
Available On Demand
The omnichannel-driven approach to promotional activity is being shaped by evolving dynamics in the life sciences market:
The behavior of the target audience is changing. Customers have an increased desire for personalized content and on-demand access.
Proliferation of data and AI is introducing more complexity to planning, execution and adoption of new ways of doing things.
Economic pressures and fear of message fatigue is leading promotional efforts to become more orchestrated and cost-efficient.
What considerations should life sciences organizations make…
Watch Now
Scientific Publications
Health Equity Frameworks – Healthcare System Actions and Priorities
Gulaid A1, Goldman E2, Skaar J1, Dehipawala S3
1Trinity Life Sciences, New York, NY, USA, 2Trinity Life Sciences, Waltham, MA, USA, 3Trinity Life Sciences, Bellerose, NY, USA
Health equity has been defined as attainment of the highest level of health for all people, regardless of race, ethnicity, disability, and/or other factors affecting access to care and health outcomes in healthcare delivery. Health equity is becoming a priority for payers and hospitals…
Read Now
Webinars
Available On Demand
Biosimilar versions of adalimumab have launched in the U.S., ending blockbuster therapy Humira’s lengthy market exclusivity and long-running commercial success. In parallel, in the creation of the Inflation Reduction Act (IRA), the U.S. joins Europe and other major markets in constraining the opportunity for medicines during their market exclusivity window. The life sciences industry now seeks to understand how the vision for commercial success will evolve while in parallel navigating new artificial intelligence (AI) and other general-purpose technologies (GPTs) technologies…
Watch Now
Blog
Published April 21, 2023
Executive Summary
Biosimilar versions of adalimumab have launched in the U.S., ending blockbuster therapy Humira’s lengthy market exclusivity and long-running commercial success.
In parallel, in the creation of the Inflation Reduction Act (IRA), the U.S. joins Europe and other major markets in constraining the opportunity for medicines during their market exclusivity window.
Trinity’s Take
These events usher in a new era for the life sciences industry, necessitating new thinking around development and commercialization strategy.
Historic reliance on the U.S. market…
Read Now
Webinars
Available On Demand
Ensuring that Patient Support Services (PSS) are inspired by the patient and accurately reflect their key areas of need is an important facet of a patient-centric approach. Come join Jennifer Parr, Partner and Head of Patient Services & Patient Centricity at Trinity and Clare Gora, Vice President & Head of Analytics Client Development at Trinity as they discuss designing optimized PSS from holistic, robust patient journeys that identify the critical patient pain points, gaps, unmet needs and moments of meaning.…
Watch Now
Webinars
Available On Demand
Assessing the impact of market events, advocacy, promotion and messaging is a key focus for Marketing and Brand leaders in life sciences. Stakeholder-perception tracking research is an often-overlooked strategic and tactical input as brands look to optimize their commercial performance. Come join Lara Lyeth, a Principal in Trinity’s Performance Tracking CoE, as she hosts a lively discussion on performance tracking with special guests Viplav Shukla, an Associate Director in Trinity’s Performance Tracking CoE, Monte Smith, a Managing Director in Trinity’s Brand &…
Watch Now
Blog
Published March 10, 2023
Executive summary
83 non-traditional Chinese medicines successfully entered the National Reimbursement Drug List (NRDL) for the first time. This is a >20% increase from the 2021 and 2020 NRDL updates, indicating the growing interest of both manufacturers and payers to ensure reimbursement for novel therapies in China.
The percentage of products achieving NRDL inclusion within one year of regulatory approval continues to increase steadily, from 24% in 2020 to 53% in the 2022 update, keeping up the strong momentum of…
Read Now
